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Abstract 
Background: Mechanisms underlying the success of Pseudomonas aeruginosa in chronic lung infection among 
cystic fibrosis (CF) patients are poorly defined. The modA gene was previously linked to in vivo competitiveness of 
P. aeruginosa by a genetic screening in the rat lung. This gene encodes a subunit of transporter ModABC, which is 
responsible for extracellular uptake of molybdate. This compound is essential for molybdoenzymes, including nitrate 
reductases. Since anaerobic growth conditions are known to occur during CF chronic lung infection, inactivation 
of a molybdate transporter could inhibit proliferation through the inactivation of denitrification enzymes. Hence, 
we performed phenotypic characterization of a modA mutant strain obtained by signature‑tagged mutagenesis 
(STM_modA) and assessed its virulence in vivo with two host models.
Results: The STM_modA mutant was in fact defective for anaerobic growth and unable to use nitrates in the growth 
medium for anaerobic respiration. Bacterial growth and nitrate usage were restored when the medium was sup‑
plemented with molybdate. Most significantly, the mutant strain showed reduced virulence compared to wild‑type 
strain PAO1 according to a competitive index in the rat model of chronic lung infection and a predation assay with 
Dictyostelium discoideum amoebae. As the latter took place in aerobic conditions, the in vivo impact of the mutation 
in modA appears to extend beyond its effect on anaerobic growth.
Conclusions: These results support the modABC‑encoded transporter as important for the pathogenesis of P. aer-
uginosa, and suggest that enzymatic machinery implicated in anaerobic growth during chronic lung infection in CF 
merits further investigation as a potential target for therapeutic intervention.
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Background
Pseudomonas aeruginosa is an environmental bacterium 
and the most common cause of chronic lung infection 
among cystic fibrosis (CF) patients [1]. Its success in 
causing opportunistic infection and its persistence capac-
ities are presumably attributable to a large 6.3–6.9 Mbp 
genome regulated by more than 550 transcriptional regu-
lators, which allow adaptation to diverse environments 
and growth conditions [2, 3]. P. aeruginosa also produces 
a wide repertoire of molecules and sensors for nutrient 
uptake, adhesion, mobility, biofilm formation and antibi-
otic resistance that are all key components of in vivo pro-
liferation [4].
It was shown that the CF mucus is oxygen-depleted 
[5] and may carry strict anaerobes [6]. Hence, during 
chronic lung infection in CF, P. aeruginosa is exposed 
to microaerophilic [7] or anaerobic conditions [8], 
which are well suited for biofilm formation [9]. Deni-
trification, the main source of energy production under 
anaerobic conditions, is based upon the reduction of 
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oxidized forms of nitrogen (preferentially nitrates, 
NO3) by metalloenzymes such as nitrate reductase [10, 
11]. Molybdate (MoO42−) is the usable form of trace-
element molybdenum (Mo) [12] and resembles sulfate, 
phosphate, tungstate and vanadate in molecular size, 
shape, charge and hydrogen-binding properties [13]. 
Mo is incorporated into the molybdenum cofactor 
(MoCo) and was found to be essential for the activity 
of molybdoenzymes. These enzymes catalyze various 
oxidation/reduction reactions and are implicated in the 
metabolism of nitrogen, carbon and sulfur. All nitrate 
reductases required for P. aeruginosa anaerobic growth 
require a MoCo cofactor [11], which can contain either 
Mo or tungsten (W) [14].
A previous PCR-based signature-tagged mutagenesis 
(PCR-STM) mutant screen allowed the identification 
of 148 genes presumably essential for in  vivo sur-
vival of P. aeruginosa PAO1 in a rat model of chronic 
lung infection [15]. One of these genes was modA. In 
E.  coli, molybdate and tungstate are internalized using 
an ATP-binding cassette transporter, ModABC [16], 
where ModA is the periplasmic binding protein with a 
high affinity for Mo/W, ModB is the integral membrane 
channel protein and ModC is the energizer protein [17]. 
In P. aeruginosa, modA was recently demonstrated to 
be essential for molybdate acquisition and anaerobic 
growth using a deletion mutant [18]. Here, with the goal 
of gaining further information on the role of ModABC 
in the virulence of P. aeruginosa, we present a charac-
terization of the PAO1 transposon mutant STM_modA. 
We then assess the relevance of modA as a therapeutic 
target by testing virulence attenuation of STM_modA in 
two host models: the rat model of chronic lung infec-
tion, which best represents the context of CF lung infec-
tions, and the amoeba predation assay, which takes 
place in aerobic conditions. Results suggest that modA 
is important for the pathogenesis of P. aeruginosa in 
both host models.
Methods
Bacterial strains, plasmids, primers and culture conditions
Bacterial strains and plasmids used in this study are listed 
in Table 1. The STM_modA mutant was constructed and 
identified in the context of PCR-based STM using strain 
PAO1 [15, 19, 20], a laboratory strain previously shown to 
be appropriate and comparable to a CF isolate (LESB58) 
for the study of virulence using the rat model of chronic 
lung infection [21]. Briefly, a tagged-miniTn5Km2 suicide 
plasmid was transferred into strain PAO1 by conjuga-
tion, generating thousands of mutants, each containing a 
unique random mutation. Mutant strains were then neg-
atively screened in pools of 72 in the rat model of chronic 
lung infection to identify defective mutants for in  vivo 
maintenance via multiplex PCR. Mutation of modA in 
the STM_modA mutant strain was confirmed by cloning 
using a plasmid rescue based on the miniTn5Km2 antibi-
otic resistance marker followed by sequencing and align-
ment on the PAO1 genome available at the Pseudomonas 
genome database [22].
For routine cultures, P. aeruginosa and E. coli were 
grown aerobically at 37 °C in tryptic soy broth (TSB) or 
Luria–Bertani (LB) broth (EMD Serono). When needed, 
culture medium was supplemented with 1.5 (w/v) % bacto 
agar, kanamycin (Km 150 μg ml−1 for STM_modA; Calbi-
ochem), ampicillin (Ap 100 μg ml−1 for DH10B transfor-
mants; Sigma-Aldrich) or carbenicillin (Cb 200 μg ml−1 
for P. aeruginosa transformants; Thermo-Fisher).
For growth experiments, P. aeruginosa was grown aero-
bically under vigorous shaking (250  rpm) in 100  ml LB 
using a 1:10 pre-culture to Erlenmeyer volume ratio. For 
anaerobic growth, nephelo flasks sealed with silicone 
stoppers containing 100 ml LB were flushed with argon 
for 45  min and needle-inoculated with 1  ml of pre-cul-
ture before incubation with weak agitation (120  rpm) 
to prevent precipitation. Media for aerobic and anaero-
bic growth were supplemented with potassium nitrate 
(KNO3; 15  mM; Merck) and, when needed, sodium 
Table 1 Strains and plasmids
Strain or plasmid Relevant characteristics Source or reference
E. coli strain
NEB 5α Chemically competent cells New England Biolabs
P. aeruginosa strains
PAO1 PAO1293, CmS, wild‑type, derivative of PAO2 which originates from PAO1 [48]
STM_modA PAO1 STM_modA::miniTn5‑Km2 mutant inactivating modA (PA1863), KmR [15]
Complemented STM_modA PAO1 STM_modA with pUCP19::modABC plasmid (PA1863, PA1862, PA1861) This study
Plasmids
pUCP19 CbR, cloning vector and used for CI [49]
pUCP19 ::modABC CbR, KmR, modABC genes on pUCP19 vector This study
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molybdate (100 μM; Sigma-Aldrich). Growth was moni-
tored by spectrophotometric measurements of optical 
density at 600  nm. Growth experiments were repeated 
three times.
Restriction enzymes, Q5 polymerase and Gibson 
assembly cloning kit were purchased from New England 
Biolabs. The QIAprep Spin Miniprep Kit (Qiagen) was 
used for plasmid isolation and the DNeasy Blood and 
Tissue kit (Qiagen) was used for genomic DNA isolation. 
PCR reactions were performed in an iCycler (Bio-Rad); 
primers used in this study are listed in Additional file 1.
Spectrophotometric determination of nitrate in culture 
medium after anaerobic growth
To determine if the STM_modA mutant was able to use 
nitrates during anaerobic growth, the concentration of 
residual nitrates in the medium was quantified after over-
night growth based on the principle of chemical reduc-
tion of nitrate and its spectrophotometric detection 
using the Griess reaction [23]. Vanadium (III) chloride 
(Sigma-Aldrich) was used for the reduction of nitrates 
to nitrites. Sulfanilamide and N-(1-naphtyl)-ethylenedi-
amine (Sigma-Aldrich) were used in the composition of 
the Griess reagent. Nitrite concentration was subtracted 
from the total nitrate and nitrite concentration to obtain 
the nitrate concentration alone.
Complementation of the STM_modA mutation
Cloning of the modABC operon into the pUCP19 vector 
was done using the Gibson Assembly Master Mix (New 
England Biolabs) following manufacturer’s instructions. 
Two overlapping PCR fragments (Additional file 1) con-
taining the entire modABC operon plus a 448 nt upstream 
region (2.1  kb final insert size) and an overlapping sec-
tion of the KpnI and PstI restriction sites were ligated 
with the digested vector. The recombinant plasmid was 
introduced by heat shock into E. coli NEB 5α chemically 
competent cells (Table 1). The plasmid transfer was first 
confirmed by EcoRI and PstI digestion followed by DNA 
sequencing. The plasmid was then recovered and elec-
troporated into the P. aeruginosa STM_modA mutant. 
Plasmid insertion in the mutant strain was confirmed 
using digestions with the same restriction enzymes.
Biofilm formation assay
Multiple phenotypic tests were performed for this study 
(see reference [24] for more information on the proto-
cols used), but only biofilm formation showed variation 
among strains. To measure the quantity of biofilm pro-
duced by wild-type strain PAO1, STM_modA, and the 
complemented STM_modA, a 96-plate rapid biofilm for-
mation assay was performed as previously described [25]. 
Briefly, strains were grown overnight in LB supplemented 
when needed with Km or Cb. The M63 culture medium 
for biofilm formation [25] was supplemented when 
needed with 100  μM sodium molybdate and 15  mM 
KNO3. Biofilms were stained with crystal violet after a 
6-hour static incubation time. Biofilm formation was 
quantified after stain dissolution in 2 × 200 μl 95 % v/v 
ethanol [26]. The experiment was done three times, with 
eight repetitions for each strain and condition. Statistical 
significance was assessed using an ANOVA in GraphPad 
Prism 6.0.
Ethics statement
The rat model in this study was used in a protocol 
approved by the “Comité de protection des animaux de 
l’Université Laval” (certificate 2011194-3, IACUC is a 
Canadian Council on Animal Care certificate holder).
Preparation of agarose bead‑embedded bacteria 
and in vivo competitive index
The previously described rat model of chronic lung infec-
tion [27] using agarose bead-embedded bacteria was 
optimized as described elsewhere [20]. Sprague–Daw-
ley rats of 450–500 g in weight were sedated (ketamine/
xylazine IP injection, 10 mg/100 g) and a local anesthetic 
(lidocaine) was applied to the vocal cords. Animals were 
then intubated and inoculated with 120 μl of bead prepa-
ration containing PAO1 + pUCP19 (CbR) strain and the 
STM_modA mutant in equal parts (1.6 × 106 CFU ml−1 
per strain) for competitive index (CI) determination. At 
day 7 post-infection, rats were euthanized by barbitu-
rate overdose (Euthanyl IP injection, 120  mg/kg) and 
homogenized lungs were diluted and plated in triplicate 
on TSA to quantify the total number of viable P. aer-
uginosa cells (TSA supplemented with 200  μg Cb ml−1 
for the wild-type selection or TSA supplemented with 
150  μg  Km  ml−1 for the mutant selection). In vivo CI 
was calculated as the ratio of mutant to wild-type bacte-
ria recovered in vivo and adjusted according to the input 
ratio. The final CI data was represented as the geometric 
mean for each group of six animals and statistical signifi-
cance was assessed with a two-tailed Mann–Whitney test 
on GraphPad Prism 6.0 software.
Amoeba predation assay
A predation assay was used to determine the bacterial 
capacity to resist to amoeba grazing [28]. The D. discoi-
deum amoeba (DH1-10) was grown in HL5 medium 
(14.3  g  l−1 of bactopeptone, 7.15  g  l−1 of yeast extract, 
18  g  l−1 of d-(+)-monohydrate maltose, 0.641  g  l−1 of 
Na2HPO4•2H2O, and 0.490  g  l−1 of KH2PO4) [29] sup-
plemented with 15 µg ml−1 tetracycline. The confluence 
of amoebae was about 60  % the day of the experiment. 
A volume of 300  µL of P. aeruginosa liquid pre-culture 
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(OD600 =  0.9) was spread in a uniform lawn on a Petri 
dish containing SM 1/10 agar (1  g  l−1 of bactopeptone, 
0.1 g l−1 of yeast extract, 0.22 g l−1 of KH2PO4, 0.1 g l−1 of 
K2HPO4, 0.1 g l−1 of MgSO4∙7H2O, 2 g l−1 of Bacto agar, 
and 1  g  l−1 of glucose). Serial 1/10 dilutions of 50,000 
amoeba cells/5 µL down to 0 cell/5 µl were deposited on 
the bacterial lawn. Petri dishes were incubated at 21  °C 
for 7  days and phagocytic plaques due to amoeba graz-
ing were monitored. The experiment was repeated three 
times.
Results and discussion
Genetic characterization of the P.aeruginosa STM_modA 
mutant
Sequencing of the mutated modA gene showed that the 
miniTn5 insertion and its typical 9-pb flanking duplica-
tion [30] were inserted in the open reading frame (ORF) 
of modA at position 540 (Fig. 1), and introduced a stop 
codon assumed to prematurely interrupt translation 
of the protein. In the 6.3 Mbp genome of P. aeruginosa 
strain PAO1, modA (PA1863) is encoded in a puta-
tive operon with modB (PA1862) and modC (PA1861) 
(Fig. 1). Their products correspond to the 26.4 kDa (252 
AA) molybdate-binding periplasmic protein precur-
sor ModA, molybdenum membrane transport protein 
ModB (24.4 kDa) and ATPase ModC (39.8 kDa). These 
annotations are based on AA identity with ModABC 
from E.coli [31], where the modABC transcription unit 
codes for an ATP-binding cassette (ABC) transporter 
of molybdate, and were confirmed by Pederick and col-
leagues [18] using a modA deletion mutant. Since ABC 
transporters require a binding protein to present the 
substrate to the cargo membrane protein(s) [32], Mod-
ABC is expected to be non-functional in the STM_modA 
mutant.
modA is required for anaerobic growth and nitrate 
utilization
Under aerobic conditions, growth of STM_modA was 
equivalent to that of wild-type PAO1. In contrast, under 
anaerobic conditions where NO3 was provided as the 
terminal electron acceptor, the STM_modA mutant was 
unable to perform productive growth (Fig.  2a). How-
ever, when the growth medium was supplemented 
with 100  μM of sodium molybdate, mutant growth was 
restored to wild-type levels. Molybdate supplementa-
tion had no effect on PAO1 growth. Wild-type modABC 
was provided in trans to the mutant strain for comple-
mentation analysis using the expression vector pUCP19. 
The complemented STM_modA strain showed PAO1-
like in  vitro growth levels under anaerobic conditions 
(Fig.  2b), which confirmed that the disruption of modA 
is responsible for the STM_modA mutant phenotype 
in anaerobic conditions and that the ModABC trans-
porter is essential for anaerobic growth. To confirm that 
this anaerobic growth defect was due to the malfunc-
tion of one or all nitrate reductases, residual nitrates in 
the growth medium were quantified (Fig.  2c). In the 
presence of nitrate reductase activity, nitrate concentra-
tion is expected to decrease due to bacterial uptake and 
subsequent reduction. After overnight growth, residual 
nitrates in the growth medium of wild-type PAO1 were 
completely consumed. In contrast, for the STM_modA 
mutant, nitrate concentration at the end of the experi-
ment was identical to the initial concentration, dem-
onstrating that no denitrification had occurred. When 
supplemented with molybdate, STM_modA showed 
PAO1-like nitrate consumption. Thus, nitrate consump-
tion is molybdate-dependent in the STM_modA mutant.
It was previously demonstrated that mod mutations 
in E. coli caused pleiotropic effects on molybdo enzyme 
Fig. 1 Genomic organization of the P. aeruginosa modABC operon in the STM_modA mutant strain. The miniTn5 transposon is inserted at position 
540. The modA gene encodes a 252 amino acid molybdate‑binding periplasmic protein precursor. Products of modB and modC are the molybde‑
num transport protein ModB and ModC, respectively. Arrows indicate the direction of transcription and numbers are relative to the transcription 
start site of modA
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activity, including nitrate reductase activity [33]. These 
effects were reversible in the presence of high concen-
trations of molybdate, which can be internalized by the 
sulfate transport system under appropriate conditions 
[16, 34]. However, sulfur compounds have been shown to 
inhibit the sulfate transport system, thus in protein-rich 
medium (such as LB), molybdate is likely internalized by 
another, less specific transporter, presumably the selenite 
transport system [34]. A novel permease (PerO) internal-
izing molybdate at micromolar concentrations was iden-
tified in Rhodobacter capsulatus [35]. PerO also imports 
sulfate, tungstate and vanadate, suggesting a general oxy-
anion transporter function. PerO has 30 % AA sequence 
identity with P. aeruginosa PAO1 PA3839, which may 
be responsible for the nonspecific uptake of molybdate 
when added at micromolar concentrations, as was done 
here for the modA mutant.
modA and biofilm formation
The STM_modA mutant strain was tested in vitro for bio-
film formation, H2O2 sensitivity, heat shock, proteolytic, 
lipolytic and hemolytic activities, swarming, twitching 
and swimming motilities, as well as pyocyanin and pyo-
verdine production. Among all tested phenotypic traits, 
only biofilm formation presented a statistically significant 
difference between STM_modA and wild-type PAO1 
(Fig. 3a). To confirm whether the weak biofilm formation 
Fig. 2 STM_modA is unable to perform anaerobic growth and use 
nitrates without molybdate supplementation. a anaerobic growth 
curves in LB medium supplemented with 15 mM KNO3, plus 100 μM 
sodium molybdate when indicated. STM_modA is unable to grow in 
anaerobic conditions with nitrates as the terminal electron accep‑
tor without molybdate supplementation. Results are from three 
independent experiments; error bars represent standard deviation 
b anaerobic overnight growth in LB medium supplemented with 
15 mM KNO3, plus 100 μM sodium molybdate when indicated. Addi‑
tion of molybdate restored growth in the STM_modA mutant. The 
complemented STM_modA strain showed growth without molyb‑
date supplementation. Statistical significance was assessed using 
an ANOVA in GraphPad prism 6.0 (*** p = 0.0003; **** p < 0.0001). c 
Residual nitrate dosage in the medium after overnight growth using 
the Griess reaction. Nitrates levels are inversely proportional to nitrate 
uptake and utilization. Adding molybdate to the medium restored 
the STM_modA mutant’s nitrate consumption. Results for b and c are 
for three technical replicates in one of three consistent experiments
Fig. 3 Quantification of biofilm formation. a Relative biofilm produc‑
tion for wild‑type PAO1 and the STM_modA mutant, in M63 medium 
supplemented with 100 μM sodium molybdate when indicated. 
Supplementation with KNO3 had no impact on these results. Statisti‑
cally significant values were obtained using an ANOVA and Fisher’s 
LSD tests in GraphPad Prism 6.0 (****p < 0.0001). Biofilm formation 
was quantified by measuring the absorbance of crystal violet‑
stained attached cells, after a 6‑hour incubation [25]. The data shown 
represent 8 replicates per strain for one of three consistent assays. 
STM_modA produces significantly less biofilm than PAO1 and this was 
not restored by the addition of molybdate and a source of electrons 
for anaerobic growth (denitrification). b Relative biofilm for PAO1, 
STM_modA and the complemented STM_modA in M63 medium. 
Biofilm formation was partly restored in the complemented strain 
(ANOVA and Fisher’s LSD, *p = 0.01, ****p < 0.0001)
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observed in STM_modA was caused by a defect in 
anaerobic growth in the presence of trace amounts of 
molybdate, the M63 medium was supplemented with 
molybdate alone, and with molybdate +  KNO3. Results 
showed that the defect was independent from molybdate 
supplementation, which implies that reduced biofilm for-
mation in STM_modA is not related to its growth defect 
in anaerobic conditions. When complemented using the 
recombinant plasmid encoding wild-type ModABC, bio-
film formation was only partially restored (Fig. 3b). These 
results differ from those of Pederick and colleagues [18], 
according to which biofilm production was unaltered in 
the modA deletion mutant in 5  ml 24  h static cultures. 
This may be due, at least in part, to important differences 
between protocols, as biofilm formation is extremely 
sensitive to growth conditions e.g. [36]. Namely, the sig-
nificant differences in volume and duration of the assay 
may have led to different oxygen gradients. If that was 
the case, it would imply that results from both studies on 
biofilm formation highlight the complex nature of this 
process in P. aeruginosa and should be interpreted with 
caution. However, since this study focusses on an inser-
tional mutant, we cannot rule out the possibility of non-
specific effects of the mutation, which may also explain 
this discrepancy. For instance, the gene adjacent to modA 
in the genome of strain PAO1, which was annotated as 
a putative transcriptional regulator, may be affected by 
the transposon insertion and result in pleiotropic effects. 
Further investigation would be required to confirm this 
gene’s function. It is noteworthy, however, that par-
tial phenotype and/or virulence rescue was previously 
observed in other complemented P. aeruginosa mutants 
see reference [37], namely in mouse models of acute 
pneumonia and burn sepsis using the same plasmid [38]. 
Therefore, it is possible that a more general mechanism, 
which remains to be described, is responsible for these 
observations.
modA is important for virulence during chronic lung 
infection
In the original screening experiment where the 
STM_modA mutant was targeted as defective for in vivo 
maintenance, pools of 72 STM mutant strains were 
tested simultaneously [15]. Therefore, further investiga-
tion was required to precisely describe the involvement 
of modA in the virulence of P. aeruginosa PAO1. An 
in vivo competitive index (CI) in the rat model of chronic 
lung infection was performed using both wild-type strain 
PAO1 and the STM_modA mutant. As depicted in Fig. 4, 
at 7 days post-infection, we recorded an in vivo CI value 
of 0.004, which represents a 250-fold decrease in mutant 
colony forming units (CFU) compared to the wild-type 
strain. Thus, STM_modA is unable to maintain a chronic 
lung infection in the rat model when in competition with 
wild-type PAO1. However, in aerobic combined culture 
conditions, PAO1 does not outcompete STM_modA, 
with an in vitro CI value of ~1.0 after 22 h. In addition, 
STM_modA was capable of normal growth in minimal 
M9 medium; hence it is not an auxotroph mutant. This 
contrast between in vitro and in vivo proliferation of the 
STM_modA mutant strain clearly stresses that mutation 
of modA has consequences that are relatively specific to 
the context of infection and probably influenced by the 
interaction with the host.
modA is important for virulence in the amoeba model
In order to further investigate the idea that the role of 
modA in virulence may be affected by interaction with 
the host, we decided to use a markedly different host 
model. D. discoideum is an alternative model for the 
study of bacterial virulence where amoebae feed by bacte-
rial uptake using phagocytosis [28, 39]. P. aeruginosa has 
universal virulence factors used to infect phylogenetically 
diverse hosts, which makes the amoeba model particu-
larly well suited to study its virulence [28, 39]. Previously 
identified virulence factors using this model, related to 
quorum sensing and the type III secretion system, were 
also essential for infection in mammalian and insect 
models [40]. Many bacterial virulence factors are active 
against predation by D. discoideum, thus virulence is 
assumed to be inversely proportional to amoeba grazing 
[29, 39]. In addition, the predation assay is performed in 
Fig. 4 In vivo competitive index (CI) of P. aeruginosa STM_modA in 
the rat lung. CI of STM_modA against wild‑type PAO1 was determined 
7 days post‑infection. Each circle represents the CI for a single animal. 
A CI of less than one indicates a virulence defect. The geometric mean 
of the CI for all rats is shown as a solid line (****p < 0.0001, Mann–
Whitney sum test)
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aerobic conditions where no growth difference has been 
noticed between PAO1 and the STM_modA mutant.
As shown in Fig.  5, the STM_modA mutant was very 
susceptible to amoeba predation as shown by the pres-
ence of phagocytic plaques with only five D. dictoste-
lium cells on a bacterial lawn of this mutant compared 
to PAO1, where a minimum of 5000 D. dictostelium 
cells was required to observe a phagocytic plaque. These 
results confirmed the virulence defect of the STM_modA 
mutant. As D. discoideum is an acute infection model 
while agar-embedded bacteria in the rat lung represent 
a chronic lung infection model, these two assays high-
light the fact that modA may be important for the global 
virulence network of P. aeruginosa, even in aerobic 
conditions.
Metabolic and molecular basis of STM_modA multi‑host 
virulence
Results presented here independently confirmed that 
transport of the trace anion molybdate is essential for 
the activity of molybdoenzymes such as nitrate reductase 
in P. aeruginosa [18]. In anaerobic conditions, molyb-
date uptake was restored in STM_modA after the addi-
tion of molybdate to the culture medium, which suggests 
less specific internalization of the molecule by a system 
other than ModABC. The lack of anaerobic growth in 
STM_modA was hypothesized to be directly linked to the 
maintenance defect observed in the rat model of chronic 
lung infection (CI = 0.004) because this model mimics CF 
lung infections, which present evidence of oxygen-deple-
tion [7–9, 41, 42]. This hypothesis, however, does not hold 
in the case of the amoeba predation assay, where a strong 
virulence defect was observed in at least partly aerobic 
conditions; oxygen availability may be limited in a fully 
grown bacterial lawn. For the biofilm formation assay, 
our results showed that STM_modA is unable to produce 
as much biofilm as PAO1 in vitro, and that this effect is 
molybdate-independent. As biofilm is a crucial compo-
nent of P.aeruginosa chronic lung infections [43], reduced 
biofilm production in STM_modA may be related to the 
virulence defect observed in the rat model of chronic lung 
infection, in conjunction with anaerobic growth defec-
tiveness. The virulence defect observed in the amoeba 
model, on the other hand, could be linked to this biofilm 
defect alone, as for other biofilm-defective mutants shown 
to have attenuated virulence in the D. dictostelium model 
[44]. Even without consideration for the biofilm results, 
which have been discussed at length earlier, the amoeba 
predation assay suggests that the impact of the mutation 
in modA may go beyond its effect on anaerobic growth, 
perhaps due to pleiotropic effects of this gene.
This study is not the first report of an impact on viru-
lence for a gene implicated in molybdate homeostasis 
in P. aeruginosa. PA1006 encodes a protein of unknown 
function implicated in molybdate homeostasis that is 
critical for biofilm maturation and virulence in a lettuce 
model and in a burned mouse acute virulence model [45]. 
Other genes implicated in molybdenum utilization and 
transport (several moe, moa and mod genes) have been 
linked to a pathogenesis defect in Mycobacterium tuber-
culosis [46]. These genes were required for intracellular 
growth in macrophages or maintenance in the organs. 
Interestingly, modA has also been identified in a STM 
experiment with M. tuberculosis using a mouse model of 
acute lung infection with an intravenous administration 
route [47].
Fig. 5 D. discoideum predation assay. STM_modA exhibits a loss of resistance to amoeba predation when compared to the wild‑type PAO1. Num‑
bers represent D. discoideum cells deposited on the bacterial lawn. The number of phagocytic plaques is inversely proportional to predation resist‑
ance. PAO1 was grazed by a minimum of 5000 cells while STM_modA was sensitive to predation by only five cells. Results were consistent among 
three independently performed assays
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Conclusions
We have shown that the inactivation of the modA gene 
in a transposon mutant caused a significant defect in P. 
aeruginosa PAO1 for the establishment of chronic lung 
infection and for resistance to D. dictostelium predation. 
This study complements previous work [18] in providing 
evidence that molybdate uptake is important for anaer-
obic growth and multi-host virulence in P. aeruginosa. 
Since the capacity to thrive in anaerobic conditions is rel-
evant to CF lung infections, the modABC-encoded trans-
porter may represent a potential target for therapeutic 
intervention and deserves further investigation.
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